Regenerative Bio
Cambridge
About Regenerative Bio
Regenerative Bio is the world's first anti-aging biotechnology company driven by artificial intelligence and cloud supercomputing, Regenerative Bio combines AI pharmaceutical-related technologies with biology to explore ingredients, formulations and therapies with anti-aging effects, and solve the problems caused by aging.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $10.0M
- Funding stage: Seed
- Last round: Angel (Feb 2022)
- Website: regen-bio.us
Industries & Categories
Artificial Intelligence (AI), Biotechnology, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/regenerative-bio-47617 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.